Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-21-064702
Filing Date
2021-12-10
Accepted
2021-12-10 16:13:09
Documents
1
Period of Report
2021-08-02

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 2116
  Complete submission text file 0001213900-21-064702.txt   3729
Mailing Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538
Business Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538 510-668-0881
ABVC BIOPHARMA, INC. (Issuer) CIK: 0001173313 (see all company filings)

EIN.: 260014658 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4823 DUNDAS STREET THOMDALE LONDON X0 N6P 1J1
Business Address
Odaira Yoshinobu (Reporting) CIK: 0001896070 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40700 | Film No.: 211485449